HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitzi Nagarkatti Selected Research

methylated bovine serum albumin (MBSA)

1/2021AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.
1/2021The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota.
1/2016Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.
1/2014Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitzi Nagarkatti Research Topics

Disease

80Inflammation (Inflammations)
12/2022 - 10/2007
35Neoplasms (Cancer)
01/2022 - 07/2002
30Colitis
06/2021 - 10/2007
15Non-alcoholic Fatty Liver Disease
01/2021 - 01/2015
15Multiple Sclerosis
01/2020 - 12/2007
14Neuroinflammatory Diseases
06/2022 - 10/2012
14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2022 - 12/2007
14Autoimmune Diseases (Autoimmune Disease)
07/2021 - 11/2003
13Body Weight (Weight, Body)
01/2018 - 08/2002
12Atrophy
11/2012 - 08/2002
11Colonic Neoplasms (Colon Cancer)
01/2022 - 09/2008
11Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2021 - 01/2012
10Dysbiosis
01/2022 - 01/2019
9Obesity
12/2020 - 01/2016
8Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2022 - 01/2014
8Cytokine Release Syndrome
11/2020 - 08/2011
8Infections
08/2020 - 06/2003
8Carcinogenesis
01/2019 - 04/2013
7Hypersensitivity (Allergy)
01/2021 - 09/2002
6Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2021 - 01/2020
5Asthma (Bronchial Asthma)
01/2022 - 08/2010
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2016
5Lung Injury
01/2020 - 11/2012
4Autoimmune Hepatitis
01/2022 - 07/2008
4COVID-19
01/2022 - 01/2020
4Fatty Liver
01/2021 - 01/2018
4Paralysis (Palsy)
01/2020 - 07/2013
4Breast Neoplasms (Breast Cancer)
06/2019 - 03/2005
4Melanoma (Melanoma, Malignant)
01/2019 - 09/2007
4Weight Loss (Weight Reduction)
01/2019 - 01/2011
4Neoplasm Metastasis (Metastasis)
12/2018 - 09/2007
4Acute Lung Injury
01/2018 - 08/2011
4Septic Shock (Toxic Shock Syndrome)
04/2015 - 01/2005
3Polyps
01/2022 - 07/2014
3Pneumonia (Pneumonitis)
11/2020 - 11/2012
3Colitis-Associated Neoplasms
08/2020 - 03/2016
3Sepsis (Septicemia)
05/2015 - 11/2013

Drug/Important Bio-Agent (IBA)

40MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
36CytokinesIBA
01/2022 - 11/2003
19ResveratrolIBA
01/2022 - 12/2007
17CannabinoidsIBA
07/2021 - 07/2002
17Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2021 - 07/2002
16Dronabinol (THC)FDA LinkGeneric
06/2021 - 07/2002
15LigandsIBA
12/2022 - 01/2011
15Polychlorinated Dibenzodioxins (TCDD)IBA
01/2022 - 09/2002
13staphylococcal enterotoxin BIBA
01/2021 - 01/2005
11Dextran SulfateIBA
08/2020 - 12/2008
9CannabidiolIBA
06/2022 - 09/2006
9Interleukin-10 (Interleukin 10)IBA
01/2022 - 04/2013
9Dextrans (Dextran)FDA Link
01/2022 - 03/2010
8Pharmaceutical PreparationsIBA
01/2022 - 08/2010
8EndocannabinoidsIBA
11/2021 - 01/2009
8SuperantigensIBA
01/2021 - 11/2003
8LeptinIBA
10/2019 - 12/2013
7AzoxymethaneIBA
01/2022 - 04/2010
7PolyphenolsIBA
01/2022 - 04/2010
7Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2011
7Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
08/2020 - 12/2007
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022 - 03/2010
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
6microcystinIBA
01/2021 - 01/2019
6AntioxidantsIBA
06/2020 - 09/2008
6AntigensIBA
01/2018 - 12/2013
5RNA (Ribonucleic Acid)IBA
06/2022 - 11/2016
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2012
5anandamide (arachidonylethanolamide)IBA
11/2021 - 07/2002
5CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2019 - 07/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2013 - 09/2008
5Interleukin-2 (IL2)IBA
04/2013 - 11/2003
4Long Noncoding RNAIBA
12/2022 - 10/2019
4methylated bovine serum albumin (MBSA)IBA
01/2021 - 01/2014
4cyanoginosin LR (microcystin LR)IBA
01/2021 - 01/2020
4HMGB1 Protein (HMG1)IBA
01/2021 - 07/2020
4Hormones (Hormone)IBA
12/2020 - 12/2013
4HexanesIBA
06/2020 - 01/2012
4Interleukin-13IBA
01/2018 - 11/2003
4ChemokinesIBA
01/2018 - 10/2012
4Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2017 - 10/2009
4IndolesIBA
02/2016 - 07/2013
3histone H3 trimethyl Lys4IBA
12/2022 - 03/2016
3OvalbuminIBA
01/2022 - 11/2017
3Histones (Histone)IBA
01/2022 - 03/2016
3Tight Junction ProteinsIBA
11/2021 - 01/2019
3InflammasomesIBA
01/2021 - 01/2019
3Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 01/2014
3Butyrates (Butyrate)IBA
01/2021 - 01/2018
3Enterotoxins (Enterotoxin)IBA
11/2020 - 04/2016
3indole-3-carbinolIBA
08/2020 - 07/2013
3sparstolonin BIBA
08/2020 - 01/2016
3Transcription Factors (Transcription Factor)IBA
06/2020 - 03/2010
3AcidsIBA
01/2020 - 01/2018
3Peroxynitrous Acid (Peroxynitrite)IBA
10/2019 - 07/2015
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 11/2017
3Interleukin-17 (Interleukin 17)IBA
01/2018 - 01/2011
3SodiumIBA
01/2018 - 01/2011
3Interleukin-12 (IL 12)IBA
04/2016 - 01/2012
3InterleukinsIBA
04/2016 - 03/2010
3Interleukin-8 (Interleukin 8)IBA
04/2016 - 11/2013
3NADPH Oxidases (NAD(P)H oxidase)IBA
01/2016 - 02/2015

Therapy/Procedure

13Therapeutics
01/2022 - 01/2012